Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

NCT07352566 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis
Atopic Dermatitis

Interventions

DEVICE: In situ cutaneous microdevice
DRUG: Triamcinolone
DRUG: 5-Fluorouracil
DRUG: Calcipotriene
DRUG: Tapinarof
DRUG: Crisaborole
DRUG: Tacrolimus
DRUG: Adalimumab
DRUG: Etanercept
DRUG: Certolizumab
DRUG: Infliximab
DRUG: Secukinumab
DRUG: Ixekizumab
DRUG: Apremilast
DRUG: Risankizumab
DRUG: Ustekinumab
DRUG: Hydroxychloroquine
DRUG: Methotrexate
DRUG: Mycophenolate
DRUG: Azathioprine

Sponsor

University of California, San Francisco